Beckman Coulter

Scopio Labs Doubles Down on Digital Cell Morphology Go-To-Market Strategy in 2023

Retrieved on:

Tuesday, February 28, 2023

Marketing, Research, Entrepreneurship, TEL, CCO, Growth, Hematology, Chief commercial officer, IPO, Beckman Coulter, WalkMe, Physician, Management

TEL AVIV, Israel, Feb. 28, 2023 /PRNewswire/ -- Scopio Labs, developer of Full-Field Digital Cell Morphology™ imaging and AI-powered analysis platforms, announced today that it will focus on the commercialization of its laboratory diagnostic solutions in 2023 to accelerate market penetration and growth.

Key Points:

Farhi joins Scopio after more than 8 years at WalkMe, where he served as the company's Chief Business Development Officer.
"In 2023, we are accelerating our commercialization strategy to increase our global impact and bring Scopio's solutions to the world.
With more exciting market developments in the pipeline, we are confident that 2023 is going to be a big year for us," said Itai Hayut, Co-Founder and CEO of Scopio Labs.
"Despite the global economic climate, Scopio experienced a significant increase in revenue over the past few months.

SCIEX collaborates with Beckman Coulter Life Sciences to bring automation to the Echo® MS system

Retrieved on:

Monday, February 27, 2023

Medical Devices, Health, Health Technology, Research, Science, Biotechnology, Genomics, SCIEX, Echo, Market development, Automation, SLAS, Beckman, Product management, CE, Management, Beckman Coulter

At SLAS 2023 , SCIEX , a global leader in life science analytical technologies, announces a new collaboration with Beckman Coulter Life Sciences , a global leader in laboratory workflow automation and innovation, to provide comprehensive workflows for high-throughput screening, HT-ADME and synthetic biology studies.

Key Points:

At SLAS 2023 , SCIEX , a global leader in life science analytical technologies, announces a new collaboration with Beckman Coulter Life Sciences , a global leader in laboratory workflow automation and innovation, to provide comprehensive workflows for high-throughput screening, HT-ADME and synthetic biology studies.
The Echo® MS system , built on Acoustic Ejection Mass Spectrometry technology from SCIEX, is now compatible with the Biomek and Echo liquid handler lines from Beckman Coulter Life Sciences.
The Beckman Coulter Life Sciences automatic liquid handling solutions are comprised of the Echo and Biomek lines.
“Collaborating with the life sciences community to accelerate answers through automation and innovative solutions is what drives us every day at Beckman Coulter Life Sciences,” said Amy Yoder, Director of Product Management for Automation and Genomics at Beckman Coulter Life Sciences.

Global Targeted Sequencing Market to Reach $10.97 Billion by 2032 - Exclusive DeepTech M-A-PTM Analysis by BIS Research

Retrieved on:

Thursday, February 23, 2023

FREMONT, Calif., Feb. 23, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Targeted Sequencing Market – A Global and Regional Analysis.

Key Points:

FREMONT, Calif., Feb. 23, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Targeted Sequencing Market – A Global and Regional Analysis.
According to this study, the global targeted sequencing market was valued at $3.19 billion in 2022 and is projected to reach $10.97 billion by 2032.
Deeper sequencing and higher depth of coverage with targeted sequencing can help avoid false interpretations of the sequencing data.
According to BIS Research's study, the global targeted sequencing market (by type of target capture) was dominated by targeted DNA sequencing segments, holding a 63.63% market share and growing with a CAGR of 13.46%.

Global Targeted Sequencing Market to Reach $10.97 Billion by 2032 - Exclusive DeepTech M-A-PTM Analysis by BIS Research

Retrieved on:

Thursday, February 23, 2023

FREMONT, Calif., Feb. 23, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Targeted Sequencing Market – A Global and Regional Analysis.

Key Points:

FREMONT, Calif., Feb. 23, 2023 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Targeted Sequencing Market – A Global and Regional Analysis.
According to this study, the global targeted sequencing market was valued at $3.19 billion in 2022 and is projected to reach $10.97 billion by 2032.
Deeper sequencing and higher depth of coverage with targeted sequencing can help avoid false interpretations of the sequencing data.
According to BIS Research's study, the global targeted sequencing market (by type of target capture) was dominated by targeted DNA sequencing segments, holding a 63.63% market share and growing with a CAGR of 13.46%.

egnite Brings Renowned Interventional Cardiologist, Rahul Sharma, onto Executive Team as Senior Medical Advisor

Retrieved on:

Thursday, February 16, 2023

egnite, Inc. , a leading digital-health company in the field of cardiovascular care, is proud to announce the appointment of Rahul P. Sharma, MD, MBBS, FRACP , as its new Senior Medical Advisor.

Key Points:

egnite, Inc. , a leading digital-health company in the field of cardiovascular care, is proud to announce the appointment of Rahul P. Sharma, MD, MBBS, FRACP , as its new Senior Medical Advisor.
A renowned interventional cardiologist, Sharma brings a wealth of knowledge and expertise to egnite’s executive team.
"We are thrilled to welcome Rahul to the egnite team," said Joel Portice, CEO of egnite.
"I am excited to join the egnite team during the next phase of growth for the company," said Sharma.

Global Targeted Sequencing Market Report 2022 to 2032: Featuring MedGenome, Novogene, PacBio. Paragon Genomics and PerkinElmer Among Others - ResearchAndMarkets.com

Retrieved on:

Monday, February 13, 2023

The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.

Key Points:

The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The growth in the global targeted sequencing market is expected to be driven by the increased use of targeted sequencing in clinical laboratories and diagnostic applications, especially in cancer research.
Targeted sequencing is a cost-effective and rapid way to detect novel and known variants in selected genetic or genomic regions.
Next-generation sequencing (NGS) is the most used method for targeted sequencing, which offers good scalability, speed, and resolution to evaluate the targeted regions of interest.

Cardiac Dimensions Appoints Angie Swenson as Vice President, Clinical Operations

Retrieved on:

Thursday, January 26, 2023

Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the appointment of Angie Swenson as Vice President of Clinical Operations.

Key Points:

Cardiac Dimensions ®, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, today announced the appointment of Angie Swenson as Vice President of Clinical Operations.
Ms. Swenson has spent most of the last 20 years leading clinical trials in the U.S., Europe, Japan and Canada and collaborating on reimbursement strategies for therapies targeting cardiovascular disease developed by leading medtech innovators.
Most recently, she served as Vice President, Clinical and Regulatory for HLT, Inc., developer of transcatheter aortic heart valve replacement (TAVR) technology, where for five years she led their early feasibility studies.
Earlier in her career, she worked for Beckman Coulter as a Clinical Studies Scientist validating projects for FDA submissions.

Liquid Handling System Market worth $5.8 billion | MarketsandMarkets

Retrieved on:

Wednesday, February 8, 2023

The automated liquid handling systems segment holds a major share of the global Liquid handling system market, By type, in 2021

Key Points:

The automated liquid handling systems segment holds a major share of the global Liquid handling system market, By type, in 2021
By type, the global Liquid handling system market is broadly segmented into electronic systems, automated systems, and manual systems.
In 2021, the Automated liquid handling systems segment dominated Liquid handling system market.
The drug discovery segment accounted for the largest share of the Liquid handling system devices market, by Application, in 2021
By application, the global Liquid handling system are classified into drug discovery, clinical diagnostics, genomics, proteomics, and other applications.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=192124302
Liquid Handling System Market Dynamics:
The major players in the Liquid Handling System are the liquid handling system market is highly consolidated and is dominated by various players.

Liquid Handling System Market worth $5.8 billion | MarketsandMarkets

Retrieved on:

Wednesday, February 8, 2023

The automated liquid handling systems segment holds a major share of the global Liquid handling system market, By type, in 2021

Key Points:

The automated liquid handling systems segment holds a major share of the global Liquid handling system market, By type, in 2021
By type, the global Liquid handling system market is broadly segmented into electronic systems, automated systems, and manual systems.
In 2021, the Automated liquid handling systems segment dominated Liquid handling system market.
The drug discovery segment accounted for the largest share of the Liquid handling system devices market, by Application, in 2021
By application, the global Liquid handling system are classified into drug discovery, clinical diagnostics, genomics, proteomics, and other applications.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=192124302
Liquid Handling System Market Dynamics:
The major players in the Liquid Handling System are the liquid handling system market is highly consolidated and is dominated by various players.

ProtaGene Appoints New Scientific and Commercial Leadership to Support Evolving Needs of Biologic and Cell & Gene Therapy Innovators

Retrieved on:

Tuesday, January 31, 2023

Chadwick, University, Business development, Thermo Fisher Scientific, Beckman Coulter, James Chadwick, Gesellschaft mit beschränkter Haftung, Hitchens, Therapy, CMC, Patient, Investment, Research, Science, LabVantage, Management, Fine chemical, Labcorp

Working in close collaboration, accomplished executive leaders Chadwick and Hitchins will utilize their respective experience to meet the rapidly evolving needs of the advanced biotherapeutics development community.

Key Points:

Working in close collaboration, accomplished executive leaders Chadwick and Hitchins will utilize their respective experience to meet the rapidly evolving needs of the advanced biotherapeutics development community.
Our elevated approach to working with partners enables us to provide analytical solutions for diverse gene therapies and complex protein-based biotherapeutics.
Prior to the formation of ProtaGene, Chadwick played several roles within the BioAnalytix organization, most recently as Vice President of Analytical Development.
Our teams are here to help our clients with important decisions as the science, industry, and regulatory expectations evolve."